Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Core EBITDA

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 22.1930.2832.74-0.120.23

What is the latest EV/Core EBITDA ratio of MANKIND PHARMA ?

The latest EV/Core EBITDA ratio of MANKIND PHARMA is 22.19 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202622.19
Mar202530.28
Mar202432.74
Mar2023-0.12
Mar20220.23

How is EV/Core EBITDA of MANKIND PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 22.19
-26.72
Mar2025 30.28
-7.51
Mar2024 32.74
Positive
Mar2023 -0.12
Negative
Mar2022 0.23 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Core EBITDA ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,003.5 Cr -5.2% 1.2% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,528.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.1% 7.6% -3.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5.2%

1.2%

-4.2%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses